ClinicalTrials.govpublic full text
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
mesothelioma, glioblastoma, renal cell carcinoma, non small cell lung cancer, melanoma, pancreatic ductal adenocarcinoma, gastric cancer, squamous cell carcinoma of head and neck, cholangiocarcinoma, breast cancer, ovarian cancer, cervical cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 803666
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.